Denosurel 120mg Injection

Denosurel 120mg Injection contains Denosumab, a targeted medication used to strengthen bones and prevent bone-related complications in patients with osteoporosis, multiple myeloma, and cancers that have spread to the bones (bone metastases). It works by blocking RANK ligand, a protein involved in bone breakdown, helping to reduce bone loss, increase bone density, and lower the risk of fractures. Clinical studies have shown that Denosumab can significantly improve bone strength in postmenopausal women with osteoporosis and individuals experiencing cancer-related bone loss. Patients receiving Denosurel 120mg Injection should ensure adequate calcium and vitamin D intake throughout treatment to support healthy bone metabolism and reduce the risk of low calcium levels. Individuals with moderate kidney impairment may require regular monitoring of renal function during therapy. This medication should not be used by patients with a known allergy to Denosumab or any of its ingredients and should be administered with caution in those with pre-existing hypoparathyroidism. As the safety and effectiveness of Denosurel 120mg Injection have not been established in children and adolescents, it is not recommended for individuals under 18 years of age. When used under medical supervision, Denosurel 120mg Injection can play an important role in protecting bone health and preventing serious skeletal complications.